Cargando…
Improving the acceptability of high-dose radiotherapy by reducing the duration of treatment: accelerated radiotherapy in high-grade glioma.
Radiotherapy, although clearly beneficial in patients with high-grade glioma, is largely palliative, and a protracted course of treatment may not be the most appropriate approach in the context of limited survival. We therefore assessed the feasibility, toxicity and survival results of a short accel...
Autores principales: | Brada, M., Thomas, G., Elyan, S., James, N., Hines, F., Ashley, S., Marsh, H., Bell, B. A., Stenning, S. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1995
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2033859/ https://www.ncbi.nlm.nih.gov/pubmed/7779733 |
Ejemplares similares
-
Radiotherapy in high grade gliomas
por: Bleehen, N.M., et al.
Publicado: (1989) -
Back to the future--radiotherapy in high grade gliomas.
por: Brada, M.
Publicado: (1989) -
Multifocal high-grade glioma radiotherapy safety and efficacy
por: Fleischmann, Daniel Felix, et al.
Publicado: (2021) -
Predictive biomarkers of resistance to hypofractionated radiotherapy in high grade glioma
por: Biau, Julian, et al.
Publicado: (2017) -
Association of high‐dose radiotherapy with improved survival in patients with newly diagnosed low‐grade gliomas
por: Liu, Yanwei, et al.
Publicado: (2021)